Sandra Ciesek News Today : Breaking News, Live Updates & Top Stories | Vimarsana

German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron : Rashtra News This will limit treatment options for Omicron-induced COVID-19, said researchers. (Representational)Frankfurt: German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, likely

The COVID-19 pandemic is officially over and the World Health Organization has declared it finished. Other news items have long superseded the coronavirus in the headlines. But in several European mainland countries, there is concern since the number of recorded infections has been rising in recent weeks

Summer is coming to an end in Germany and the number of COVID-19 cases is starting to increase again. Is this the beginning of a new post-pandemic wave of infection?

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

NIST researcher Megan Cleveland uses a PCR machine to amplify DNA sequences by copying them numerous times through a series of chemical reactions